Glucocorticoid tapering and associated outcome in patients with newly diagnosed systemic lupus erythematosus: the real-world GULP prospective observational study

OBJECTIVE: A subanalysis of the multicentre Early Lupus inception cohort was performed to investigate the real-world Glucocorticoids (GCs) Use in newly diagnosed systemic lupus erythematosus (SLE) Patients (GULP). METHODS: Patients starting prednisone (PDN) ≥5 mg/day and concomitant hydroxychloroqui...

Descripción completa

Detalles Bibliográficos
Autores principales: Floris, Alberto, Chessa, Elisabetta, Sebastiani, Gian Domenico, Prevete, Immacolata, Iannone, Florenzo, Coladonato, Laura, Govoni, Marcello, Bortoluzzi, Alessandra, Mosca, Marta, Tani, Chiara, Doria, Andrea, Iaccarino, Luca, Franceschini, Franco, Fredi, Micaela, Conti, Fabrizio, Spinelli, Francesca Romana, Bellisai, Francesca, D'Alessandro, Roberto, Zanetti, Anna, Carrara, Greta, Scirè, Carlo Alberto, Cauli, Alberto, Piga, Matteo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Lupus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806067/
https://www.ncbi.nlm.nih.gov/pubmed/36581383
http://dx.doi.org/10.1136/rmdopen-2022-002701

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806067/
https://www.ncbi.nlm.nih.gov/pubmed/36581383
http://dx.doi.org/10.1136/rmdopen-2022-002701

Ejemplares similares